Clinical benefits persist 5 years after thymectomy for myasthenia gravisJanuary 31, 2019Rare DiseasesNeurology
Phase 3 studies of antiamyloid Alzheimer’s drug crenezumab stoppedJanuary 31, 2019GeriatricsNeurology
Race/ethnicity, other factors predict PTSD and depression after mild TBIJanuary 30, 2019Mental HealthNeurology
SPRINT MIND published: Extension trial to add 2 years’ follow-upJanuary 28, 2019Preventive CareCardiologyGeriatricsNeurology
